Funding transnational collaborative research through joint transnational calls is one of the major objectives of E-Rare. This is the most important and effective joint activity to enhance the cooperation between European scientists working on rare diseases and thus reducing the fragmentation of research in this field. E-Rare launches calls on a yearly basis. The topic and eligibility criteria are specified every year and therefore may vary from one call to the other.

Germany
Israel
Quebec
REALS
Repurposed Enoxacin for the treatment of patients with Amyotrophic Lateral Sclerosis

Project Coordinator

Weizmann Institute of Science
Rehovot
Israel

Partners

Angela Genge McGill University Montreal, Québec (Canada)
Erik Storkebaum Max Plank Institute for Molecular Biomedicine Münster, Germany

E-Rare 2012 - Created by Toussaint Biger